GenAI and Authorship in Academia: The (Im)Possible Creator. An Integrative Review
Discourses on Culture · 01.06.2026 · 25 (1) · 79-109
DOI: 10.2478/doc-2026-0004 ↗Kurz gefasst
Fachartikel in der Zeitschrift Discourses on Culture, online erschienen am 03.07.2026. Verfasst von Irena Vassileva und 1 weiteren Autor:innen. Die Arbeit nennt 63 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).
Abstract (Originalsprache)
Amid vivid ethical discussions on using AI to assist scholars in the writing process, this contribution tackles the question about Generative AI and authorship from a philosophy of language and academic perspective. In this integrative review, we look into the ways Generative AI impacts the very notion of authorship on the stages of knowledge production, knowledge consumption and knowledge dissemination. We focus on the implications of using Large Language Models with their enhanced capabilities of generating convincing imitations of human natural language for our conception of authorship. Contextualizing this capability to the realm of academic production, we seek to explore whether generative AI is going to further add to the postmodern destruction of the author, and how it relates to a core aspect of academic integrity, namely acknowledging the intellectual contributions of other scholars.
Zitieren
APA
Vassileva, I., & Chankova, M. (2026). GenAI and Authorship in Academia: The (Im)Possible Creator. An Integrative Review. Discourses on Culture, 25(1), 79-109. https://doi.org/10.2478/doc-2026-0004
Vancouver
Vassileva I, Chankova M. GenAI and Authorship in Academia: The (Im)Possible Creator. An Integrative Review. Discourses on Culture. 2026;25(1):79-109. doi:10.2478/doc-2026-0004
BibTeX
@article{Vassileva2026,
author = {Vassileva, Irena and Chankova, Mariya},
title = {GenAI and Authorship in Academia: The (Im)Possible Creator. An Integrative Review},
journal = {Discourses on Culture},
year = {2026},
volume = {25},
number = {1},
pages = {79--109},
doi = {10.2478/doc-2026-0004}
}
EUVIMED